157 related articles for article (PubMed ID: 8116170)
1. Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992).
van der Kolk JH; Kalsbeek HC; van Garderen E; Wensing T; Breukink HJ
Vet Rec; 1993 Dec; 133(24):594-7. PubMed ID: 8116170
[TBL] [Abstract][Full Text] [Related]
2. Adrenocorticotropin-containing neoplastic cells in a pars intermedia adenoma in a horse.
Horvath CJ; Ames TR; Metz AL; Larson VL
J Am Vet Med Assoc; 1988 Feb; 192(3):367-71. PubMed ID: 2833479
[TBL] [Abstract][Full Text] [Related]
3. [A horse with Cushing's disease].
van der Kolk JH; Klein WR; van der Putten SW; Mol JA
Tijdschr Diergeneeskd; 1991 Jul; 116(13):670-5. PubMed ID: 1650504
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in thoroughbreds.
Okada T; Shimomuro T; Oikawa M; Nambo Y; Kiso Y; Morikawa Y; Liptrap RM; Yamashiro S; Little PB; Sasaki F
Am J Vet Res; 1997 Aug; 58(8):920-4. PubMed ID: 9256982
[TBL] [Abstract][Full Text] [Related]
5. Hormonal response to thyrotropin-releasing hormone in healthy horses and in horses with pituitary adenoma.
Beech J; Garcia M
Am J Vet Res; 1985 Sep; 46(9):1941-3. PubMed ID: 3931519
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma.
van der Kolk JH; Heinrichs M; van Amerongen JD; Stooker RC; in de Wal LJ; van den Ingh TS
Am J Vet Res; 2004 Dec; 65(12):1701-7. PubMed ID: 15631037
[TBL] [Abstract][Full Text] [Related]
7. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
Beech J; Boston R; Lindborg S; Russell GE
J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
[TBL] [Abstract][Full Text] [Related]
8. Lipid metabolism in horses with hyperadrenocorticism.
van der Kolk JH; Wensing T; Kalsbeek HC; Breukink HJ
J Am Vet Med Assoc; 1995 Apr; 206(7):1010-2. PubMed ID: 7768707
[TBL] [Abstract][Full Text] [Related]
9. Laboratory diagnosis of equine pituitary pars intermedia adenoma.
van der Kolk JH; Wensing T; Kalsbeek HC; Breukink HJ
Domest Anim Endocrinol; 1995 Jan; 12(1):35-9. PubMed ID: 7621678
[TBL] [Abstract][Full Text] [Related]
10. Equine intravenous glucose tolerance test: glucose and insulin responses of healthy horses fed grain or hay and of horses with pituitary adenoma.
Garcia MC; Beech J
Am J Vet Res; 1986 Mar; 47(3):570-2. PubMed ID: 3516026
[TBL] [Abstract][Full Text] [Related]
11. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma.
Eiler H; Oliver JW; Andrews FM; Fecteau KA; Green EM; McCracken M
J Am Vet Med Assoc; 1997 Jul; 211(1):79-81. PubMed ID: 9215417
[TBL] [Abstract][Full Text] [Related]
12. [Clinical symptoms of and diagnostic possibilities for hypophyseal adenoma in horses].
Feige K; Eser MW; Geissbühler U; Balestra E; Metzler K
Schweiz Arch Tierheilkd; 2000 Feb; 142(2):49-54. PubMed ID: 10697998
[TBL] [Abstract][Full Text] [Related]
13. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.
Miller MA; Pardo ID; Jackson LP; Moore GE; Sojka JE
Vet Pathol; 2008 Jan; 45(1):26-38. PubMed ID: 18192571
[TBL] [Abstract][Full Text] [Related]
14. Adenoma of the pars intermedia and hirsutism in a pony.
Holscher MA; Linnabary RL; Netsky MG; Owen HD
Vet Med Small Anim Clin; 1978 Sep; 73(9):1197-200. PubMed ID: 252364
[No Abstract] [Full Text] [Related]
15. Age-related Qualitative Histological and Quantitative Stereological Changes in the Equine Pituitary.
Leitenbacher J; Herbach N
J Comp Pathol; 2016; 154(2-3):215-24. PubMed ID: 26810844
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.
Beech J; Boston RC; McFarlane D; Lindborg S
J Am Vet Med Assoc; 2009 Sep; 235(6):715-22. PubMed ID: 19751169
[TBL] [Abstract][Full Text] [Related]
17. [Anorexia in a pony with Cushing's disease].
van der Kolk JH; van Hoorn CJ; van Garderen E; van den Belt AJ
Tijdschr Diergeneeskd; 1993 May; 118(9):298-300. PubMed ID: 8387700
[TBL] [Abstract][Full Text] [Related]
18. Adenomas of the pars intermedia associated with hyperglycemia and glycosuria in two horses.
Loeb WF; Capen CC; Johnson LE
Cornell Vet; 1966 Oct; 56(4):623-39. PubMed ID: 6008349
[No Abstract] [Full Text] [Related]
19. [Hypophyseal adenocarcinoma in a horse. A case study].
Martens J; Rosenbruch M
Tierarztl Prax; 1984; 12(3):354-8. PubMed ID: 6495317
[TBL] [Abstract][Full Text] [Related]
20. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
Copas VE; Durham AE
Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
